PER49 Antibody

Shipped with Ice Packs
In Stock

Description

Applications in Research

  • Western Blot (WB): Detects PER49 at concentrations as low as 1 ng, enabling analysis of expression under stress conditions .

  • ELISA: High titer (10,000) ensures sensitivity for quantitative assays .

  • Functional Studies: Useful for investigating peroxidase roles in lignin biosynthesis, pathogen defense, and reactive oxygen species (ROS) scavenging .

Pricing and Packages (Abmart) :

PackageComponentsPriceDelivery TimeQuality Assurance
X3 -O23237N, C, and M combinations$1,19930 daysAbInsure™ coverage
Single regionN, C, or M combination$59930 daysStandard validation

Abmart’s AbInsure™ program guarantees reagent performance, reflecting industry efforts to address the "antibody characterization crisis" through rigorous validation .

Validation and Best Practices

While PER49 antibodies are pre-validated for ELISA and WB, researchers should:

  • Confirm specificity using Arabidopsis knockout mutants (if available) .

  • Compare results across N, C, and M terminus-targeting antibodies to rule off-target binding .

  • Utilize epitope mapping services to deconvolute monoclonal mixtures for precise applications .

Limitations and Future Directions

No peer-reviewed studies directly using PER49 antibodies were identified in the surveyed literature. Further research should:

  • Characterize PER49’s role in Arabidopsis stress responses using these tools.

  • Explore cross-reactivity with peroxidases in other plant species.

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 Weeks (Made-to-Order)
Synonyms
PER49 antibody; DIDI antibody; 6G-3B antibody; P49 antibody; At4g36430 antibody; AP22.54 antibody; C7A10.930 antibody; Peroxidase 49 antibody; Atperox P49 antibody; EC 1.11.1.7 antibody; ATP31 antibody
Target Names
PER49
Uniprot No.

Target Background

Function
The target protein is involved in several key biological processes, including hydrogen peroxide removal, oxidation of toxic reducing agents, lignin biosynthesis and degradation, suberization, auxin catabolism, and responses to environmental stresses such as wounding, pathogen attack, and oxidative stress. The specific functions may vary depending on the isozyme/isoform and plant tissue.
Database Links

KEGG: ath:AT4G36430

STRING: 3702.AT4G36430.1

UniGene: At.4607

Protein Families
Peroxidase family, Classical plant (class III) peroxidase subfamily
Subcellular Location
Secreted.

Q&A

What is PER49 and what are its key characteristics in plant biology?

PER49 (Peroxidase 49) is a member of the peroxidase superfamily proteins found in Arabidopsis thaliana (Mouse-ear cress). This protein is encoded by the gene AT4G36430 (also known as AP22.54 or AP22_54) . As a class III peroxidase (EC 1.11.1.7), PER49 plays important roles in plant stress responses, participating in reactive oxygen species (ROS) metabolism, lignification processes, and defense mechanisms against pathogens. The protein contains characteristic peroxidase domains and catalyzes oxidation-reduction reactions using hydrogen peroxide as an electron acceptor. PER49 is part of a large peroxidase family in Arabidopsis, which includes more than 70 members with potentially overlapping yet distinct functions in plant development and stress responses.

Peroxidases like PER49 are particularly important in plant tissues undergoing active development or responding to environmental stressors, as indicated by studies examining stress proteome changes in Arabidopsis roots . Understanding the specific functions of PER49 can provide insights into fundamental plant biology processes including cell wall modifications, stress signaling pathways, and adaptive responses to environmental challenges.

What are the most common applications of PER49 antibodies in plant research?

PER49 antibodies have several important applications in plant research, with Western blotting and ELISA being the most widely utilized techniques. According to available product information, commercially available anti-PER49 polyclonal antibodies are specifically validated for ELISA and Western blot applications . These applications allow researchers to:

  • Detect and quantify PER49 protein expression in different plant tissues

  • Monitor changes in PER49 levels during development or in response to environmental stimuli

  • Compare PER49 expression across different genotypes or treatment conditions

  • Study post-translational modifications that may affect PER49 function

  • Investigate the subcellular localization of PER49 through immunohistochemistry techniques

For Western blot applications, these antibodies help ensure proper identification of the antigen through specific binding to the PER49 protein . The availability of both recombinant PER49 protein and anti-PER49 antibodies provides researchers with valuable tools for studying this important enzyme in plant biological processes.

How should researchers validate the specificity of PER49 antibodies?

Validating antibody specificity is crucial for ensuring reliable experimental results when studying PER49. Researchers should implement a multi-step validation approach:

  • Genetic validation: Compare signal between wild-type and PER49 knockout/knockdown plants. A specific antibody should show significantly reduced or absent signal in plants lacking or having reduced PER49 expression.

  • Biochemical validation: Conduct pre-adsorption tests by incubating the antibody with purified recombinant PER49 protein before application to samples. This competitive binding should eliminate specific signal if the antibody is truly PER49-specific.

  • Molecular weight confirmation: Verify that the antibody recognizes a protein band of the expected molecular weight for PER49 (approximately 35-40 kDa for the mature protein) in Western blot analyses.

  • Cross-reactivity assessment: Test the antibody against recombinant proteins of closely related peroxidases to assess potential cross-reactivity. This is particularly important as the Arabidopsis genome encodes multiple peroxidase family members with similar structural features.

  • Signal-to-noise evaluation: Compare specific signal to background across different antibody dilutions to determine optimal working concentrations . For accurate quantification, researchers must correct for the presence of inactive antibody molecules, which can constitute approximately 0.55% of immunopurified antibody preparations .

What controls are essential for PER49 antibody experiments?

Proper experimental controls are critical for interpreting results from PER49 antibody experiments. The following controls should be incorporated:

Negative Controls:

  • Samples from PER49 knockout/knockdown plants

  • Primary antibody omission control (secondary antibody only)

  • Isotype control (non-specific IgG from the same species as the PER49 antibody)

Positive Controls:

  • Purified recombinant PER49 protein

  • Samples from plants known to express high levels of PER49

  • Tissues with confirmed PER49 expression

Technical Controls:

  • Loading controls for Western blots (housekeeping proteins or total protein staining)

  • Dilution series to confirm linearity of detection

  • Pre-adsorption control (antibody pre-incubated with antigen)

When using ELISA for quantitative measurements, researchers should include standard curves with known concentrations of purified PER49 protein. Additionally, the detection method should be carefully calibrated to account for the presence of inactive antibody molecules (approximately 0.55%) in immunopurified antibody preparations, which can significantly affect quantitative measurements, especially for high-affinity antibodies .

What factors affect PER49 antibody binding efficiency?

Several factors can significantly impact PER49 antibody binding efficiency in experimental settings:

  • Post-translational modifications: Peroxidases like PER49 undergo various modifications including glycosylation and phosphorylation. These modifications can alter epitope accessibility and affect antibody recognition.

  • Sample preparation: The method of protein extraction and sample preparation can influence antigen conformation and epitope exposure. Harsh extraction conditions may denature proteins and affect antibody binding.

  • Buffer composition: The pH, ionic strength, and presence of detergents in buffers can all influence antibody-antigen interactions. Optimizing buffer conditions is essential for maximizing specific binding while minimizing background.

  • Antibody quality: The purity and storage conditions of antibodies directly impact their performance. Degraded or aggregated antibodies may show reduced binding efficiency or increased non-specific binding.

  • Antigen concentration: As demonstrated in studies of antibody affinity, the ratio of antibody to antigen affects binding kinetics. In antibody excess, univalent binding may occur, while in antigen excess, bivalent antibody binding is typically observed, resulting in approximately 15 times higher avidity .

  • Inactive antibody molecules: The presence of inactive antibody molecules in preparations (approximately 0.55% in immunopurified preparations) necessitates data correction when performing quantitative measurements, particularly when working with high-affinity antibodies .

How can researchers optimize PER49 detection in plant tissue sections?

Optimizing PER49 detection in plant tissue sections requires careful attention to sample preparation, fixation, and immunostaining protocols. The following comprehensive approach is recommended:

Sample Fixation and Preparation:

  • Use gentle fixatives such as 4% paraformaldehyde in phosphate buffer (pH 7.2-7.4) for 2-4 hours

  • Perform careful dehydration through an ethanol series (30%, 50%, 70%, 90%, 100%)

  • Use embedding media that preserve antigenicity (e.g., LR White resin)

  • Section tissues at optimal thickness (3-5 μm for paraffin, 1-2 μm for resin)

Antigen Retrieval:

  • If needed, perform heat-induced epitope retrieval using citrate buffer (pH 6.0)

  • Monitor time and temperature carefully to prevent tissue damage

Immunostaining Protocol:

  • Block with 3-5% BSA or 5% non-fat dry milk in phosphate buffer with 0.1% Triton X-100

  • Apply optimized dilution of primary anti-PER49 antibody (typically 1:100 to 1:500)

  • Incubate at 4°C overnight for maximal sensitivity

  • Wash thoroughly with phosphate buffer containing 0.1% Tween-20

  • Apply appropriate labeled secondary antibody (1:200 to 1:1000)

  • Include DAPI or other counterstains to provide cellular context

For each new tissue type or experimental condition, researchers should perform antibody dilution series tests to determine optimal concentrations that maximize specific signal while minimizing background. When working with highly autofluorescent plant tissues, consider using enzymatic detection methods (e.g., HRP-DAB) instead of fluorescent labeling.

What strategies help distinguish PER49 from other peroxidase family members?

Distinguishing PER49 from other peroxidase family members presents a significant challenge due to sequence and structural similarities. Researchers can employ several strategies to achieve specificity:

  • Epitope-specific antibodies: Use antibodies raised against unique peptide regions of PER49 that have minimal homology with other peroxidases. This approach requires careful epitope selection based on comprehensive sequence alignment analysis of the peroxidase family.

  • Genetic approaches: Implement gene-specific knockout or knockdown lines of PER49 as negative controls to confirm antibody specificity. The comparison between wild-type and knockout samples provides strong evidence for antibody specificity.

  • Recombinant protein panels: Test antibody reactivity against a panel of recombinant peroxidase proteins to assess cross-reactivity profiles. This can help establish the selectivity of the antibody for PER49 versus other family members.

  • Mass spectrometry validation: Following immunoprecipitation with anti-PER49 antibodies, analyze the precipitated proteins by mass spectrometry to confirm their identity as PER49 rather than other peroxidases.

  • Immunodepletion experiments: Sequentially deplete samples with antibodies against different peroxidases before detecting with anti-PER49 antibodies to reduce potential cross-reactivity.

The challenge of distinguishing between closely related peroxidases highlights the importance of using multiple, complementary approaches to validate findings related to PER49-specific expression or function.

How can researchers accurately quantify PER49 levels in plant extracts?

Accurate quantification of PER49 levels in plant extracts requires careful attention to methodological details and appropriate controls. A comprehensive approach includes:

Sample Preparation Considerations:

  • Use standardized extraction protocols optimized for peroxidases

  • Include protease inhibitors to prevent degradation

  • Control for extraction efficiency across samples

  • Consider cell wall-bound versus soluble protein fractions

Quantification Methods:

  • ELISA-based quantification: Develop standard curves using purified recombinant PER49 . Correct for the presence of inactive antibody molecules (approximately 0.55% in immunopurified preparations) as these can significantly affect measurements .

  • Western blot densitometry: Include a dilution series of recombinant PER49 on each blot to create a standard curve. Use total protein normalization methods (e.g., Ponceau S staining) rather than single housekeeping proteins for more reliable quantification.

  • Activity-based quantification: Measure peroxidase activity using PER49-preferred substrates, but be aware that activity measurements may reflect contributions from multiple peroxidases.

Data Analysis Considerations:

  • Ensure measurements fall within the linear range of detection

  • Apply appropriate statistical methods for comparing samples

  • Account for matrix effects in complex plant extracts

  • When using high-affinity antibodies, apply mathematical corrections for the presence of inactive antibody molecules

Researchers should validate their quantification method by comparing results across different techniques and by demonstrating reproducibility across biological replicates.

What are the key methodological considerations for studying PER49 under stress conditions?

When studying PER49 under stress conditions, researchers should consider several methodological factors to ensure reliable and interpretable results:

Experimental Design:

  • Include appropriate controls for each stress treatment

  • Implement time-course analyses to capture dynamic responses

  • Use multiple biological replicates (minimum three) to account for plant-to-plant variation

  • Consider tissue-specific responses, as peroxidase expression often varies between plant organs

Stress Application Protocols:

  • Standardize stress application methods to ensure reproducibility

  • Monitor stress intensity using established physiological markers

  • Document environmental conditions throughout the experiment

  • Consider both acute and chronic stress exposures

Analytical Approaches:

  • Combine transcript analysis (qRT-PCR) with protein detection (Western blot)

  • Include enzyme activity assays to assess functional changes

  • Consider post-translational modifications that may affect PER49 function under stress

  • Normalize data appropriately using stress-stable reference genes/proteins

Data Interpretation:

  • Distinguish between direct and indirect effects of stress on PER49

  • Consider potential compensatory responses from other peroxidases

  • Correlate PER49 changes with physiological or biochemical stress markers

  • Compare PER49 responses across different stress types to identify specific vs. general stress responses

Researchers examining the stress proteome in Arabidopsis roots should use well-defined experimental protocols with multiple independent replicates to ensure robust and reproducible results .

How can researchers develop and validate new antibodies against PER49?

Developing and validating new antibodies against PER49 requires a systematic approach:

Antigen Design and Production:

  • Select unique regions of PER49 with low homology to other peroxidases

  • Consider both peptide antigens (for epitope-specific antibodies) and recombinant protein (for broader recognition)

  • Ensure proper protein folding for recombinant antigens

  • Verify antigen purity by SDS-PAGE and mass spectrometry

Immunization Strategy:

  • Select appropriate host species based on intended applications

  • Implement optimal immunization schedule with appropriate adjuvants

  • Monitor antibody titers throughout the immunization process

  • Consider multiple host animals to increase chances of success

Antibody Screening and Purification:

  • Develop a genotype-phenotype linked antibody screening system to rapidly identify antigen-specific clones

  • Implement NGS-compatible methods to facilitate high-throughput screening

  • Purify antibodies using antigen-affinity chromatography for highest specificity

  • Characterize antibody isotype and concentration

Validation Process:

  • Test reactivity against wild-type and PER49 knockout plants

  • Assess cross-reactivity with related peroxidases

  • Determine binding kinetics using surface plasmon resonance

  • Evaluate performance in multiple applications (Western blot, ELISA, immunohistochemistry)

  • Measure affinity constants to assess binding strength

Documentation:

  • Document all validation steps thoroughly

  • Provide detailed protocols for optimal use

  • Specify working dilutions for different applications

  • Include information about epitope location and potential limitations

The development of specific molecular probes requires careful design and extensive validation to ensure their utility in research applications .

What are common sources of false positives in PER49 immunodetection and how can they be mitigated?

False positives in PER49 immunodetection can arise from several sources, each requiring specific mitigation strategies:

Cross-reactivity with related peroxidases:

  • Use antibodies raised against unique PER49 epitopes

  • Validate specificity using PER49 knockout plants

  • Perform pre-adsorption controls with recombinant proteins of related peroxidases

Non-specific binding of primary antibody:

  • Optimize blocking conditions (use 3-5% BSA or 5% non-fat dry milk)

  • Increase washing stringency (add 0.1-0.3% Tween-20 to wash buffers)

  • Titrate antibody concentration to minimize background

  • Use antigen-affinity purified antibodies rather than crude serum

Secondary antibody issues:

  • Include secondary-only controls to assess non-specific binding

  • Use highly cross-adsorbed secondary antibodies

  • Match secondary antibody to the host species of primary antibody

Endogenous enzyme activity:

  • Include inhibition steps for endogenous peroxidases when using HRP-conjugated detection systems

  • Block endogenous biotin when using biotin-streptavidin detection systems

Detection system artifacts:

  • Include substrate-only controls

  • Optimize exposure times for Western blots or incubation times for ELISA

  • Be aware that approximately 0.55% of inactive antibody molecules in immunopurified preparations can affect quantitative measurements

Data interpretation pitfalls:

  • Distinguish between specific signal and background

  • Use appropriate statistical analyses

  • Consider technical and biological variability

  • Validate findings using complementary techniques

Implementing these strategies can significantly improve the reliability of PER49 detection and reduce false positive results.

How should researchers address weak or inconsistent PER49 antibody signals?

Weak or inconsistent PER49 antibody signals are common challenges that can be addressed through systematic optimization:

Sample preparation optimization:

  • Modify protein extraction buffers to improve solubilization

  • Add protease inhibitors to prevent degradation

  • Optimize protein concentration loading

  • Consider native versus denaturing conditions

Antibody-related adjustments:

  • Test different antibody concentrations

  • Extend primary antibody incubation time (overnight at 4°C)

  • Evaluate different antibody lots or sources

  • Consider using antibody enhancer solutions

Detection system enhancement:

  • Switch to more sensitive detection methods (e.g., from colorimetric to chemiluminescent)

  • Use signal amplification systems (biotin-streptavidin or tyramide amplification)

  • Optimize substrate concentration and incubation time

  • Extend exposure times for Western blots

Protocol modifications:

  • Adjust blocking conditions to reduce competition for epitope binding

  • Modify washing stringency

  • Test different membrane types for Western blotting

  • Consider antigen retrieval methods for tissue sections

Troubleshooting decision tree:

  • If signal is absent in all samples: Check antibody functionality with positive controls

  • If signal is weak but specific: Focus on sensitivity enhancement

  • If signal is inconsistent between replicates: Address sample preparation variability

  • If signal deteriorates over time: Evaluate antibody storage conditions

Careful documentation of optimization steps can help establish reliable protocols for consistent PER49 detection across experiments.

What factors affect the shelf-life and stability of PER49 antibodies?

The shelf-life and stability of PER49 antibodies depend on several critical factors that researchers should carefully manage:

Storage conditions:

  • Temperature: Store at -20°C for long-term or at 4°C for short-term use

  • Aliquoting: Prepare small single-use aliquots to minimize freeze-thaw cycles

  • Additives: Include glycerol (50%) for freeze protection and sodium azide (0.02%) as preservative

  • Container material: Use low-protein binding tubes

Stability-affecting factors:

  • Freeze-thaw cycles: Each cycle can reduce activity by 5-20%

  • Bacterial contamination: Can lead to proteolytic degradation

  • pH fluctuations: Extreme pH can denature antibodies

  • Protein concentration: Very dilute solutions (<0.1 mg/mL) may lose activity more rapidly

  • Chemical contaminants: Oxidizing agents and heavy metals can damage antibody structure

Monitoring antibody performance:

  • Include positive controls in each experiment to track antibody performance over time

  • Document lot numbers and preparation dates

  • Compare signal intensity across experiments to detect decreasing activity

  • Consider periodic validation with PER49 recombinant protein

Extending antibody lifespan:

  • Add carrier proteins (BSA, 0.1-1%) to dilute antibody solutions

  • Use sterile technique when handling antibodies

  • Consider commercial antibody stabilizers for diluted working solutions

  • Avoid exposing antibodies to strong light, especially when conjugated to fluorophores

Proper attention to these factors can significantly extend the useful life of PER49 antibodies and ensure consistent experimental results over time.

How can researchers optimize PER49 antibody dilutions for different applications?

Optimizing PER49 antibody dilutions for different applications requires systematic testing and consideration of application-specific factors:

Western Blotting Optimization:

  • Start with manufacturer's recommended dilution (typically 1:1000 to 1:5000)

  • Perform a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000, 1:10000)

  • Evaluate signal-to-noise ratio at each dilution

  • Consider membrane type (PVDF vs. nitrocellulose) when optimizing

  • Adjust based on detection method (chemiluminescent, fluorescent, or colorimetric)

ELISA Optimization:

  • Create an antibody dilution curve (typically starting at 1:100 to 1:10000)

  • Plot OD values against antibody dilution

  • Select dilution in the steep part of the sigmoid curve

  • Account for plate type and blocking reagents

  • Consider the presence of inactive antibody molecules (approximately 0.55%) when quantifying results

Immunohistochemistry Optimization:

  • Start with higher concentrations than for Western blot (1:50 to 1:500)

  • Test multiple dilutions on the same tissue section when possible

  • Evaluate specific signal versus background staining

  • Consider fixation method and incubation times

  • Adjust based on detection system (fluorescent vs. enzymatic)

Optimization Strategy:

  • Create a standardized validation protocol for each application

  • Document optimal conditions for each antibody lot

  • Include positive controls to normalize across experiments

  • Consider that different tissues may require different dilutions

ApplicationStarting Dilution RangeKey ConsiderationsOptimization Metric
Western Blot1:1000 - 1:5000Protein amount, detection methodSignal-to-noise ratio
ELISA1:500 - 1:5000Coating conditions, blocking reagentStandard curve linearity
Immunohistochemistry1:50 - 1:500Fixation method, incubation timeSpecific signal vs. background
Flow Cytometry1:100 - 1:1000Cell permeabilization, incubation timeSeparation from isotype control

For any application, the optimal antibody concentration is one that provides maximum specific signal with minimal background staining.

What are best practices for storing and handling plant samples for PER49 detection?

Proper storage and handling of plant samples is critical for preserving PER49 integrity and ensuring reliable detection:

Sample Collection:

  • Collect samples quickly and consistently across experiments

  • Minimize tissue damage to reduce artifactual changes in peroxidase activity

  • Document developmental stage and growth conditions

  • Consider diurnal variations in gene expression

Immediate Processing:

  • Flash-freeze samples in liquid nitrogen immediately after collection

  • Process fresh samples within 30 minutes of collection if freezing isn't possible

  • Keep samples on ice during processing

  • Use RNase-free techniques if analyzing both protein and transcript levels

Long-term Storage:

  • Store frozen samples at -80°C for protein analysis

  • Avoid repeated freeze-thaw cycles

  • Use airtight containers to prevent freeze-drying

  • Label comprehensively with date, tissue type, and treatment

Extraction Considerations:

  • Include protease inhibitors in extraction buffers

  • Add reducing agents (e.g., DTT) to preserve native protein structure

  • Control pH carefully as peroxidase activity is pH-sensitive

  • Consider separate extractions for soluble and cell wall-bound peroxidases

  • Maintain cold temperature throughout extraction process

Quality Control:

  • Assess protein integrity by SDS-PAGE before immunodetection

  • Check for peroxidase activity using general substrates

  • Measure total protein concentration to ensure consistent loading

  • Document sample storage time and conditions

Following these practices helps ensure that observed variations in PER49 levels reflect true biological differences rather than artifacts of sample handling or storage.

How should researchers design experiments to compare PER49 across different plant tissues?

Designing experiments to compare PER49 across different plant tissues requires careful planning to ensure valid comparisons:

Sampling Strategy:

  • Collect multiple tissue types at the same developmental stage

  • Sample from plants grown under identical conditions

  • Consider biological replicates (minimum n=3) for each tissue type

  • Document precise anatomical locations for each sample

  • Harvest all tissues within a narrow time window to control for circadian effects

Extraction Protocol Considerations:

  • Develop tissue-specific extraction protocols if necessary

  • Normalize extraction buffer volume to tissue weight

  • Adjust homogenization methods based on tissue hardness

  • Include tissue-specific controls for extraction efficiency

  • Consider separate protocols for soluble and cell wall-bound peroxidases

Analytical Approaches:

  • Combine protein detection (Western blot) with activity assays

  • Include transcript analysis (qRT-PCR) to correlate with protein levels

  • Consider immunolocalization to identify cell-specific expression

  • Use consistent loading controls appropriate for each tissue type

Data Normalization:

  • Normalize to total protein content rather than single reference proteins

  • Consider tissue-specific internal controls

  • Apply appropriate statistical methods for multi-tissue comparisons

  • Account for tissue-specific interfering compounds

Visualization Approaches:

  • Present data as relative expression across tissues

  • Use heatmaps to visualize tissue-specific patterns

  • Include anatomical context in data presentation

  • Correlate PER49 levels with tissue-specific functions

This experimental design enables robust comparison of PER49 expression patterns across different plant tissues while minimizing technical variables that could confound biological differences.

What approaches help determine if observed PER49 signals are specific?

Determining the specificity of PER49 signals requires a multi-faceted approach incorporating several validation strategies:

Genetic Validation:

  • Compare signals between wild-type and PER49 knockout/knockdown plants

  • Test for signal reduction in RNAi or CRISPR-modified plants with reduced PER49 expression

  • Examine signal in PER49 overexpression lines (should show increased intensity)

  • Test closely related but distinct peroxidase knockout lines (signal should remain)

Biochemical Validation:

  • Perform antibody pre-adsorption with purified recombinant PER49 protein

  • Test competitive inhibition with free PER49 peptides

  • Compare signals using multiple antibodies targeting different PER49 epitopes

  • Perform peptide mapping to confirm the identity of detected proteins

Analytical Validation:

  • Confirm expected molecular weight in Western blots

  • Verify subcellular localization is consistent with known peroxidase distribution

  • Check that expression patterns match transcript data

  • Compare results across multiple detection methods

Controls to Include:

  • Positive control (recombinant PER49 protein)

  • Negative control (PER49 knockout tissue)

  • Isotype control (non-specific IgG from same species)

  • Secondary antibody-only control

  • Closely related peroxidase detection as specificity control

These approaches collectively provide strong evidence for signal specificity and help distinguish true PER49 detection from technical artifacts or cross-reactivity with related proteins.

How can researchers effectively study post-translational modifications of PER49?

Studying post-translational modifications (PTMs) of PER49 requires specialized approaches:

Identification Strategy:

  • Use phospho-specific or glyco-specific staining methods to detect modified proteins

  • Employ mass spectrometry-based proteomics for comprehensive PTM mapping

  • Use specific enzymes (phosphatases, glycosidases) to remove modifications and observe mobility shifts

  • Apply 2D gel electrophoresis to separate differentially modified PER49 forms

Modification-Specific Antibodies:

  • Generate or obtain antibodies specific to modified forms of PER49

  • Validate antibody specificity using in vitro modified recombinant PER49

  • Perform parallel detection with pan-PER49 and modification-specific antibodies

  • Include appropriate controls (in vitro modified vs. unmodified protein)

Functional Analysis:

  • Compare enzymatic activity of modified vs. unmodified PER49

  • Study the effect of PTMs on protein stability and localization

  • Investigate how modifications affect protein-protein interactions

  • Develop mutation studies (e.g., phospho-null or phospho-mimetic mutations)

Experimental Considerations:

  • Add appropriate protease and phosphatase inhibitors during extraction

  • Consider enrichment methods for modified proteins before analysis

  • Use gentle extraction conditions to preserve labile modifications

  • Document treatment conditions that may alter modification status

Data Interpretation:

  • Quantify the ratio of modified to unmodified PER49

  • Correlate modifications with specific biological conditions

  • Consider the dynamic nature of many PTMs

  • Integrate findings with known regulatory pathways

This comprehensive approach enables researchers to characterize the types, locations, and functional consequences of post-translational modifications on PER49.

What are the key considerations for multiplexing PER49 detection with other proteins?

Multiplexing PER49 detection with other proteins requires careful planning to ensure accurate simultaneous detection:

Antibody Selection:

  • Choose antibodies from different host species to avoid cross-reactivity

  • Ensure each antibody has been validated independently

  • Verify that antibodies perform well under identical experimental conditions

  • Select antibodies targeting proteins with distinct molecular weights

Detection System Design:

  • For Western blots, use differentially labeled secondary antibodies

  • For immunofluorescence, ensure fluorophores have well-separated excitation/emission spectra

  • Test for potential bleed-through between detection channels

  • Consider sequential rather than simultaneous antibody application if necessary

Optimization Steps:

  • Test each antibody individually before combining

  • Determine optimal concentration for each antibody in the multiplex setting

  • Adjust blocking and washing conditions to work for all antibodies

  • Validate that detection of one protein doesn't interfere with others

Controls for Multiplexing:

  • Single antibody controls alongside multiplex detection

  • Secondary antibody-only controls for each detection channel

  • Samples expressing only one of the target proteins when possible

  • Signal displacement controls (physical separation of expected signals)

Data Analysis Considerations:

  • Correct for spectral overlap in fluorescence applications

  • Normalize each signal to appropriate controls

  • Consider differential expression levels when interpreting results

  • Verify co-localization using appropriate statistical methods

Effective multiplexing enables researchers to study PER49 in the context of other proteins of interest, such as related peroxidases or proteins involved in the same biological pathways.

How can researchers design longitudinal studies to track PER49 changes over time?

Designing longitudinal studies to track PER49 changes over time requires careful planning to ensure consistent sampling and analysis:

Experimental Design:

  • Establish clear time points based on developmental stages or treatment intervals

  • Use sufficient biological replicates at each time point (minimum n=3)

  • Consider parallel time courses with different treatments

  • Include appropriate controls at each time point

  • Plan for tissue-specific sampling if relevant

Sample Management:

  • Develop a consistent sampling protocol for all time points

  • Process all samples from a time series simultaneously when possible

  • If processing must be staggered, include reference samples across batches

  • Store samples consistently to minimize degradation

  • Document exact sampling times and conditions

Analytical Approach:

  • Process all samples from a time series in parallel

  • Include internal time point controls on each gel/blot

  • Apply consistent detection and quantification methods

  • Use the same antibody lot throughout the study

  • Include technical replicates at each time point

Data Analysis:

  • Apply appropriate statistical methods for time-series data

  • Account for both biological and technical variability

  • Consider both absolute and relative changes in PER49 levels

  • Correlate PER49 changes with other measured parameters

  • Use visualization techniques suitable for temporal data (line graphs, heat maps)

Validation Strategies:

  • Confirm key findings with independent biological replicates

  • Verify important time points using complementary detection methods

  • Correlate protein-level changes with transcript data

  • Consider functional assays to link expression changes to biological outcomes

This approach enables researchers to robustly track PER49 dynamics over time while controlling for technical variables that could confound true biological changes.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.